Methods and challenges in timing chromosomal abnormalities within cancer samples

Bioinformatics

Volumn 29, Issue 24, 2013, Pages 3113-3120

  Purdom, Elizabeth ^a   Ho, Christine ^a   Grasso, Catherine S ^b   Quist, Michael J ^b   Cho, Raymond J ^c   Spellman, Paul ^b   Kelso, Janet ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BAYES THEOREM; CHROMOSOME ABERRATION; COMPUTER SIMULATION; FEMALE; GENETICS; HUMAN; OVARY TUMOR; SKIN TUMOR; STATISTICAL MODEL; TIME;

BAYES THEOREM; CHROMOSOME ABERRATIONS; COMPUTER SIMULATION; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; OVARIAN NEOPLASMS; SKIN NEOPLASMS; TIME FACTORS;

EID: 84900374826     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btt546     Document Type: Article

References (33)

1. Attolini, C. et al. (2010) A mathematical framework to determine the temporal sequence of somatic genetic events in cancer. Proc. Natl Acad. Sci. USA, 107, 17604-17609.
2. Beerenwinkel, N. et al. (2005a) Learning multiple evolutionary pathways from cross sectional data. J. Comput. Biol., 12, 584-598.
3. Beerenwinkel, N. et al. (2005b) Mtreemix: a software package for learning and using mixture models of mutagenetic trees. Bioinformatics, 21, 2106-2107.
4. Beerenwinkel, N. et al. (2006) Evolution on distributive lattices. J. Theor. Biol., 242, 409-420.
5. Beroukhim, R. et al. (2007) Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl Acad. Sci. USA, 104, 20007-20012.
6. Bilke, S. (2005) Inferring a tumor progression model for neuroblastoma from genomic data. J. Clin. Oncol., 23, 7322-7331.
7. Brodeur, G. et al. (1982) Statistical analysis of cytogenetic abnormalities in human cancer cells. Cancer Genet. Cytogenet., 7, 137-152.
8. Campbell, P.J. et al. (2008) Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proc. Natl Acad. Sci. USA, 105, 13081-13086.
9. Cancer Genome Atlas Research Network. (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455, 1061-1068.
10. Cancer Genome Atlas Research Network. (2011) Integrated genomic analyses of ovarian carcinoma. Nature, 474, 609-615.
11. Desper, R. et al. (2000) Distance-based reconstruction of tree models for oncogenesis. J. Comput. Biol., 7, 789-803.
12. Durinck, S. et al. (2011) Temporal dissection of tumorigenesis in primary cancers. Cancer Discov., 1, 137-143.
13. Fearon, E. and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
14. Frumkin, D. et al. (2008) Cell lineage analysis of a mouse tumor. Cancer Res., 68, 5924-5931.
15. Gerlinger, M. et al. (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Eng. J. Med., 366, 883-892.
16. Gerstung, M. et al. (2009) Quantifying cancer progression with conjunctive Bayesian networks. Bioinformatics, 25, 2809-2815.
17. Greenman, C.D. et al. (2012) Estimation of rearrangement phylogeny for cancer genomes. Genome Res., 22, 346-361.
18. Hjelm, M. et al. (2006) New probabilistic network models and algorithms for oncogenesis. J. Comput. Biol., 13, 853-865.
19. Huang, H. et al. (2007) Bayesian analysis of frequency of allelic loss data. J. Am. Stat. Assoc., 102, 1245-1253.
20. Liu, J. et al. (2009) Inferring progression models for CGH data. Bioinformatics, 25, 2208-2215.
21. Navin, N.E. and Hicks, J. (2010) Tracing the tumor lineage. Mol. Oncol., 4, 267-283.
22. Newton, M.A. (2002) Discovering combinations of genomic aberrations associated with cancer. J. Am. Stat. Assoc., 97, 931-942.
23. Newton, M.A. and Lee, Y. (2000) Inferring the location and effect of tumor suppressor genes by instability-selection modeling of allelic-loss data. Biometrics, 56, 1088-1097.
24. Newton, M.A. et al. (1994) Assessing the significance of chromosome-loss data: where are suppressor genes for bladder cancer? Stat. Med., 13, 839-858.
25. Newton, M. et al. (1998) On the statistical analysis of allelic-loss data. Stat. Med., 17, 1425-1445.
26. Nik-Zainal, S. et al. (2012) The life history of 21 breast cancers. Cell, 149, 994-1007.
27. Nishizaki, T. et al. (1997) Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer, 19, 267-272.
28. Rahnenfuhrer, J. et al. (2005) Estimating cancer survival and clinical outcome based on genetic tumor progression scores. Bioinformatics, 21, 2438-2446.
29. Sasatomi, E. et al. (2002) Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value. Cancer Res., 62, 2681-2689.
30. Siegmund, K.D. et al. (2009) Inferring clonal expansion and cancer stem cell dynamics from DNA methylation patterns in colorectal cancers. Proc. Natl Acad. Sci. USA, 106, 4828-4833.
31. Simon, R. et al. (2000) Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis. GGenes Chromosomes Cancer, 28, 106-120.
32. Sprouffske, K. et al. (2011) Accurate reconstruction of the temporal order of mutations in neoplastic progression. Cancer Prev. Res., 4, 1135-1144.
33. Taylor, B.S. et al. (2008) Functional copy-number alterations in cancer. PLoS One, 3, e3179.